A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
An impurity of Efavirenz. Efavirenz is an antiretroviral medication used for the treatment of HIV/AIDS. Synonyms: (S)-6-Chloro-4-(pent-1-ynyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one. CAS No. 205755-86-8. Molecular formula: C14H11ClF3NO2. Mole weight: 317.69.
Efavirenz quinoline analog
An impurity of Efavirenz, a nonnucleoside HIV-1 reverse transcriptase inhibitor and antiviral agent. Synonyms: 2-Cyclopropyl-6-chloro-4-(trifluoromethyl)quinoline. Grade: > 95%. CAS No. 391860-73-4. Molecular formula: C13H9ClF3N. Mole weight: 271.67.
Efavirenz Racemic
United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standardsimpurity standardspharmaceutical toxicology. Alternative Names: Efavirenz Racemic, ((+/-)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one).
Efavirenz Ready Made Solution
10 mg/mL in DMSO. Group: Fluorescence/luminescence spectroscopy.
Efavirenz Related Compound A
United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards.
Efavirenz Related Compound B
An impurity of Efavirenz. Efavirenz is an antiretroviral medication used for the treatment of HIV/AIDS. Synonyms: Efavirenz ethene analog; (4S)-6-Chloro-4-[(1E)-2-cyclopropylethenyl]-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-Benzoxazin-2-one; USP Efavirenz Related Compound B. Grade: > 95%. CAS No. 440124-96-9. Molecular formula: C14H11ClF3NO2. Mole weight: 317.69.
Efavirenz Related Compound B
United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards.
Efavirenz Related Compound C
United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards.
Efavirenz (Sustiva, MDP-266, L-743726)
A nonnucleoside HIV-1 reverse transcriptase inhibitor. Group: Biochemicals. Alternative Names: (4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; DMP 266; L 743726; Stocrin; Sustiva. Grades: Highly Purified. CAS No. 154598-52-4. Pack Sizes: 250mg, 500mg, 1g. Molecular Formula: C14H9ClF3NO2, Molecular Weight: 315.67. US Biological Life Sciences.
Worldwide
Efbemalenograstim alfa
Efbemalenograstim alfa (F 627) is a recombinant fusion protein. Efbemalenograstim alfa is a long acting dimeric granulocyte colony-stimulating factor (G-CSF) that contains two human G-CSF fused to a human immunoglobulin G2 (hIgG2)-Fc fragment with a peptide linker. Efbemalenograstim alfa induces the production of white blood cells [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Benegrastim; Bineuta; F 627. CAS No. 2200269-79-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99879.
EFdA-TP
EFdA-TP is a potent nucleoside reverse transcriptase (RT) inhibitor. EFdA-TP inhibits HIV-1 RT with multiple mechanisms. Synonyms: 2'-Deoxy-4'-Ethynyl-2-Fluoroadenosine 5'-(Tetrahydrogen Triphosphate); Islatravir triphosphate. Grade: ≥98%. CAS No. 950913-56-1. Molecular formula: C12H15FN5O12P3. Mole weight: 533.19.
EFdA-TP tetraammonium
EFdA-TP tetraammonium is a potent inhibitor of nucleoside reverse transcriptase (RT). It inhibits RT-catalyzed DNA synthesis as an effective immediate or delayed chain terminator (ICT or DCT). EFdA-TP tetraammonium inhibits HIV-1 RT with multiple mechanisms. Grade: 95%. Molecular formula: C12H27FN9O12P3. Mole weight: 601.32.
EFdA-TP tetrasodium
EFdA-TP tetrasodium is a potent inhibitor of nucleoside reverse transcriptase (RT). EFdA-TP tetrasodium inhibits HIV-1 RT with multiple mechanisms. Molecular formula: C12H11FN5Na4O12P3. Mole weight: 621.12.
Effervellen impurity3
Effervellen impurity3. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1132642-95-5. Molecular formula: C14H4D5ClF3NO2. Mole weight: 320.71. Catalog: APB1132642955.
Effusol
Effusol. Group: Biochemicals. Alternative Names: 5-Ethenyl-9,10-dihydro-1-methyl-2,7-phenanthrenediol; NSC 371300. Grades: Highly Purified. CAS No. 73166-28-6. Pack Sizes: 10mg. Molecular Formula: C17H16O2. US Biological Life Sciences.
Worldwide
Effusol
Effusol is a metabolite of Dihydrophenanthrene that is found in the Juncus effusus L. Effusol. It exhibits antitumor activity. Synonyms: 5-ethenyl-1-methyl-9,10-dihydrophenanthrene-2,7-diol; 1-methyl-5-vinyl-9,10-dihydrophenanthrene-2,7-diol. Grade: >98%. CAS No. 73166-28-6. Molecular formula: C17H16O2. Mole weight: 252.313.
Effususol A
Effususol A is a natural compound used in the research of various types of cancer. With its unique chemical composition, this product has shown promising results in inhibiting the growth and proliferation of tumor cells. Grade: 98.0%. CAS No. 1869082-58-5. Molecular formula: C18H20O3. Mole weight: 284.355.
EFIN
EFIN. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 9,9-Dimethyl-N,N-diphenyl-7-(4-(1-phenyl-1H-benzo[d]imidazol-2-yl)phenyl)-9H-fluoren-2-amine. Product Category: Organic Light Emitting Diode (OLED). CAS No. 1705571-72-7. Molecular formula: C46H35N3. Mole weight: 629.79 g/mol. Product ID: ACM1705571727. Alfa Chemistry ISO 9001:2015 Certified. Categories: Efinaconazole.
Efinaconazole
Efinaconazole is a triazole antifungal. It is approved for use in Canada and the USA as a 10% topical solution for the treatment of onychomycosis (fungal infection of the nail). Efinaconazole acts as a 14α-demethylase inhibitor. Efinaconazole inhibits fungal lanosterol 14α-demethylase involved in the biosynthesis of ergosterol, a constituent of fungal cell membranes. Efinaconazole has been shown to be active against isolates of the following microorganisms, both in vitro and in clinical infections. Efinaconazole exhibits in vitro minimum inhibitory concentrations (MICs) of 0.06 μg/mL or less against most ( ≥ 90%) isolates of the following microorganisms: Trichophyton rubrum; Trichophyton mentagrophytes. Uses: Designed for use in research and industrial production. Additional or Alternative Names: KP103; KP-103; KP 103; CTK5J2975; AGJ95634; KB145948; Efinaconazole; trade name: Jublia. Product Category: Inhibitors. Appearance: Solid powder. CAS No. 164650-44-6. Molecular formula: C18H22F2N4O. Mole weight: 348.39. Purity: >98%. IUPACName: (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol. Canonical SMILES: C[C@@H](N1CCC(CC1)=C)[C@@](O)(C2=CC=C(F)C=C2F)CN3N=CN=C3. Product ID: ACM164650446. Alfa Chemistry ISO 9001:2015 Certified.
Efinaconazole
Efinaconazole (KP-103) is a triazole antifungal agent and againsts T. mentagrophytes SM-110 and C. albicans ATCC 10231 with MICs of 0.0039 μg/mL and 0.00098 μg/mL, respectively [1]. Efinaconazole has a potent in vitro activity against fungal pathogens including dermatophytes, Candida and Malassezia species [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: KP-103. CAS No. 164650-44-6. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-15660.
Efinaconazole
?98% (HPLC). Group: Fluorescence/luminescence spectroscopypharma & vet compounds & metabolitespharma & vet compounds & metabolites. Alternative Names: (?R,?R)-?-(2,4-Difluorophenyl)-?-methyl-4-methylene-?-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidineethanol, 1-Piperidineethanol, ?-(2,4-difluorophenyl)-?-methyl-4-methylene-?-(1H-1,2,4-triazol-1-ylmethyl)-, [R-(R*,R*)]-, Efinaconazole, KP 103, Jublia,1-Piperidineethanol, ?-(2,4-difluorophenyl)-?-methyl-4-methylene-?-(1H-1,2,4-triazol-1-ylmethyl)-, (?R,?R)-, KP 103 (pharmaceutical).
Efinaconazole
Efinaconazole is a triazole antifungal. It is approved for use in Canada and the USA as a 10% topical solution for the treatment of onychomycosis (fungal infection of the nail). Efinaconazole acts as a 14α-demethylase inhibitor. Efinaconazole inhibits fungal lanosterol 14α-demethylase involved in the biosynthesis of ergosterol, a constituent of fungal cell membranes. Efinaconazole has been shown to be active against isolates of the following microorganisms, both in vitro and in clinical infections. Efinaconazole exhibits in vitro minimum inhibitory concentrations (MICs) of 0.06 μg/mL or less against most ( ≥ 90%) isolates of the following microorganisms: Trichophyton rubrum; Trichophyton mentagrophytes. Synonyms: KP103; KP-103; KP 103; CTK5J2975; AGJ95634; KB145948; AGJ 95634; KB 145948; AGJ-95634; KB-145948; Efinaconazole; trade name: Jublia. Grade: >98%. CAS No. 164650-44-6. Molecular formula: C18H22F2N4O. Mole weight: 348.39.
Efinaconazole
Efinaconazole is a topical antifungal for onychomycosis. Group: Biochemicals. Alternative Names: (αR, βR)-α-(2,4-Difluorophenyl)- β-methyl-4-methylene-α-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidineethanol; [R-(R*,R*)]-α-(2,4-Difluorophenyl)- β-methyl-4-methylene-α-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidineethanol; KP 103; KP 103. Grades: Highly Purified. CAS No. 164650-44-6. Pack Sizes: 500mg, 1g. Molecular Formula: C??H??F?N?O, Molecular Weight: 348.39. US Biological Life Sciences.
Worldwide
Efinaconazole (2R,3R)-diol O-methanesulfonate
An impurity of Efinaconazole. Efinaconazole is a potent topical antifungal medication used primarily to treat onychomycosis (gray nail disease) caused by dermatophytes such as Trichophyton rubrum and Trichophyton mentagrophytes. Synonyms: 2,3-Butanediol, 2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-, 3-methanesulfonate, [R-(R*,R*)]-; (2R,3R)-3-(2,4-Difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl methanesulfonate; (2R,3R)-2-(2,4-Difluorophenyl)-3-methanesulfonyloxy-1-(1H-1,2,4-triazol-1-yl)-2-butanol; Efinaconazole Impurity 30. Grade: ≥95%. CAS No. 133775-26-5. Molecular formula: C13H15F2N3O4S. Mole weight: 347.34.
Efinaconazole 2R,3R Epoxy triazole
An enantiomer of Efinaconazole, a triazole antifungal approved to treat fungal infections of the toenails as a topical solution. Synonyms: 1-[[(2R,3R)-2-(2,4-Difluorophenyl)-3-methyloxiranyl]methyl]-1H-1,2,4-triazole; (2R-trans)-1-[[2-(2,4-Difluorophenyl)-3-methyloxiranyl]methyl]-1H-1,2,4-triazole. Grade: > 95%. CAS No. 135270-13-2. Molecular formula: C12H11F2N3O. Mole weight: 251.23.
Efinaconazole (2R,3R) Regiamer
An impurity of Efinaconazole, a triazole antifungal approved to treat fungal infections of the toenails as a topical solution. Synonyms: (2R,3R)-2-(2,4-Difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(4H-1,2,4-triazol-4-yl)butan-2-ol. Grade: 95%. CAS No. 2122222-10-8. Molecular formula: C18H22F2N4O. Mole weight: 348.4.
Efinaconazole (2R,3S) Distereomer
An impurity of Efinaconazole, a triazole antifungal approved to treat fungal infections of the toenails as a topical solution. Grade: 90%. CAS No. 2055038-60-1. Molecular formula: C18H22F2N4O. Mole weight: 348.4.
Efinaconazole (2S,3R) Distereomer
An impurity of Efinaconazole, a triazole antifungal approved to treat fungal infections of the toenails as a topical solution. Grade: 90%. CAS No. 2055038-61-2. Molecular formula: C18H22F2N4O. Mole weight: 348.4.
Efinaconazole 2S,3S Epoxy triazole
An enantiomer of Efinaconazole, a triazole antifungal approved to treat fungal infections of the toenails as a topical solution. Synonyms: 1-[[(2S,3S)-2-(2,4-Difluorophenyl)-3-methyloxiranyl]methyl]-1H-1,2,4-triazole; (2S-trans)-1-[[2-(2,4-Difluorophenyl)-3-methyloxiranyl]methyl]-1H-1,2,4-triazole. Grade: > 95%. CAS No. 135270-10-9. Molecular formula: C12H11F2N3O. Mole weight: 251.23.
Efinaconazole Diol triazole (2R,3R)
A useful synthetic intermediate in the synthesis of Efinaconazole. Synonyms: (2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol Methanesulfonate. Grade: 90%. CAS No. 1175536-50-1. Molecular formula: C13H17F2N3O5S. Mole weight: 365.35.
Efinaconazole Diol triazole (2S,3R)
An impurity of efinaconazole. Efinaconazole is a triazole antifungal. Synonyms: (2S,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol. Grade: 90%. CAS No. 135272-36-5. Molecular formula: C12H13F2N3O2. Mole weight: 269.25.
Efinaconazole Impurity 30
Efinaconazole Impurity 30. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (2R,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diyl dimethanesulfonate. CAS No. 153522-54-4. Molecular formula: C14H17F2N3O6S2. Mole weight: 425.43. Catalog: APB153522544.
Efinaconazole Impurity 44
Efinaconazole Impurity 44. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (2R,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol. CAS No. 133775-25-4. Molecular formula: C12H13F2N3O2. Mole weight: 269.25. Catalog: APB133775254.
Efinaconazole Impurity 50
Efinaconazole Impurity 50. Uses: For analytical and research use. Group: Impurity standards. CAS No. 133775-26-5. Molecular formula: C13H15F2N3O4S. Mole weight: 347.34. Catalog: APB133775265.
Efinaconazole-N-oxide
An impurity of Efinaconazole, a triazole antifungal approved to treat fungal infections of the toenails as a topical solution. Synonyms: 1-((2R,3R)-3-(2,4-Difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)-4-methylenepiperidine 1-oxide. CAS No. 2055038-63-4. Molecular formula: C18H22F2N4O2. Mole weight: 364.4.
Efinaconazole Related Impurity 3
The S,S-enantiomer of Efinaconazole, a medication used to treat toenail infection caused by fungus. Synonyms: ent-Efinaconazole; (2S,3S)-Efinaconazole; (αS,βS)-α-(2,4-Difluorophenyl)-β-methyl-4-methylene-α-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidine ethanol; [S-(R*,R*)]-α-(2,4-Difluorophenyl)-β-methyl-4-methylene-α-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidine ethanol. Grade: > 95%. CAS No. 164650-45-7. Molecular formula: C18H22F2N4O. Mole weight: 348.39.
Efinaconazole Related Impurity 4
An enantiomer of Efinaconazole, a triazole antifungal approved to treat fungal infections of the toenails as a topical solution. Synonyms: Efinaconazole 2S,3R Epoxy triazole; 1-(((2S,3R)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole; 1-{[(2S,3R)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl]methyl}-1H-1,2,4-triazole; (2S,3R)-2-(2,4-difluorophenyl)-3-methyl-2-(1H-1,2,4-triazol-1-yl)methyloxirane. Grade: > 95%. CAS No. 135270-07-4. Molecular formula: C12H11F2N3O. Mole weight: 251.24.
Efinaconazole THP DIOL (2R,3R)
An impurity of Efinaconazole, a triazole antifungal approved to treat fungal infections of the toenails as a topical solution. Grade: 95%. CAS No. 135133-23-2. Molecular formula: C17H21F2N3O3. Mole weight: 353.36.
Efineptakin alfa
Efineptakin alfa (NT-17) is a long-acting recombinant human IL-7. Efineptakin alfa supports the proliferation and survival CD4 + and CD8 + cells in both human and mice. Efineptakin alfa can be used for glioblastoma research [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: NT-17. CAS No. 2026634-47-7. Pack Sizes: 1 mg; 5 mg. Product ID: HY-P99908.
Eflornithine
Eflornithine is a difluoromethylated ornithine compound with antineoplastic activity. Eflornithine irreversibly inhibits ornithine decarboxylase, an enzyme required for polyamine biosynthesis, thereby inhibiting the formation and proliferation of tumor cells. Polyamines are involved in nucleosome oligomerization and DNA conformation, creating a chromatin environment that stimulates neoplastic transformation of cells. This agent has been shown to induce apoptosis in leiomyoma cells. Synonyms: Ornithine, 2-(difluoromethyl)-; 2-(Difluoromethyl)ornithine; 2-(Difluoromethyl)-DL-ornithine; DL-2-(Difluoromethyl)ornithine; DL-α-(Difluoromethyl)ornithine; DFMO; DFMO (growth regulator); Difluromethylornithine; Elfornithine; MDL 71782; MDL 71782A; Ornidyl; RFI 71782; RMI 71782; α,δ-Diamino-α-(difluoromethyl)valeric acid; α-(Difluoromethyl)-DL-ornithine; α-(Difluoromethyl)ornithine. Grade: ≥95%. CAS No. 70052-12-9. Molecular formula: C6H12F2N2O2. Mole weight: 182.17.
Eflornithine
Eflornithine is a specific, irreversible inhibitor of the enzyme ornithine decarboxylase. Eflornithine is a medication for the treatment of African trypanosomiasis and excessive facial hair growth in women. Uses: Scientific research. Group: Signaling pathways. Alternative Names: DFMO; MDL71782; RMI71782; α-difluoromethylornithine. CAS No. 70052-12-9. Pack Sizes: 100 mg; 500 mg. Product ID: HY-B0744.
Eflornithine hydrochloride
Eflornithine hydrochloride is a specific, irreversible inhibitor of the enzyme ornithine decarboxylase. Eflornithine is a medication for the treatment of African trypanosomiasis and excessive facial hair growth in women. Uses: Scientific research. Group: Signaling pathways. Alternative Names: DFMO hydrochloride; MDL71782 hydrochloride; RMI71782 hydrochloride; α-difluoromethylornithine hydrochloride. CAS No. 68278-23-9. Pack Sizes: 100 mg; 500 mg. Product ID: HY-B0744A.
Eflornithine hydrochloride
Eflornithine hydrochloride is a drug found to be effective in the treatment of facial hirsutism. It is a "suicide inhibitor," irreversibly binding to Ornithine Decarboxylase (ODC) and preventing the natural substrate ornithine from accessing the active site. Synonyms: DFMO hydrochloride; MDL71782 hydrochloride; RMI71782 hydrochloride; MDL 71782 hydrochloride; RMI 71782 hydrochloride; MDL-71782 hydrochloride; RMI-71782 hydrochloride; α-difluoromethylornithine hydrochloride; Vaniqa hydrochloride. Grade: >98%. CAS No. 68278-23-9. Molecular formula: C6H13ClF2N2O2. Mole weight: 218.63.
Eflornithine hydrochloride
United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards.
Eflornithine hydrochloride
Eflornithine hydrochloride. Group: Biochemicals. Alternative Names: DFMO; DL-2-(Difluoromethyl)-ornithine hydrochloride. Grades: Highly Purified. CAS No. 68278-23-9. Pack Sizes: 5g, 10g, 25g, 50g, 100g. Molecular Formula: C6H12F2N2O2·HCl. US Biological Life Sciences.
Worldwide
Eflornithine hydrochloride hydrate
Eflornithine hydrochloride hydrate (DFMO hydrochloride hydrate) is a specific, irreversible inhibitor of the enzyme ornithine decarboxylase. Eflornithine hydrochloride hydrate is a medication for the treatment of African trypanosomiasis and excessive facial hair growth in women [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: DFMO hydrochloride hydrate; MDL-71782 hydrochloride hydrate; RMI-71782 hydrochloride hydrate; α-difluoromethylornithine hydrochloride hydrate. CAS No. 96020-91-6. Pack Sizes: 10 mM * 1 mL; 100 mg; 500 mg. Product ID: HY-B0744B.
Eflornithine hydrochloride, hydrate
Eflornithine hydrochloride, hydrate is a drug found to be effective in the treatment of facial hirsutism. It is a "suicide inhibitor," irreversibly binding to Ornithine Decarboxylase (ODC) and preventing the natural substrate ornithine from accessing the active site. It is an irreversible inhibitor of ornithine decarboxylase that suppresses polyamine biosynthesis. It displays antiangiogenic and cytostatic effects in tumor cells but must be used in combination with other chemotherapeutic agents to negate compensatory increases in polyamine content through alternate synthesis pathways. It also demonstrates antiparasitic activity in a model of C. parvum infection. Synonyms: DFMO hydrochloride hydrate; MDL-71782 hydrochloride hydrate; RMI-71782 hydrochloride hydrate; MDL 71782 hydrochloride hydrate; RMI 71782 hydrochloride hydrate; MDL71782 hydrochloride hydrate; RMI71782 hydrochloride hydrate; α-difluoromethylornithine hydrochloride hydrate; Vaniqa hydrochloride hydrate. Grade: 98%. CAS No. 96020-91-6. Molecular formula: C6H15ClF2N2O3. Mole weight: 236.64.
Eflornithine Hydrochloride Monoydrate
Irreversible inhibitor of ornithine decarboxylase, an enzyme involved in polyamine biosynthesis. Antineoplastic; antipneumocystic; antiprotozoal (Trypanosoma). Used in the treatment of hirsutism. Group: Biochemicals. Alternative Names: 2-(Difluoromethyl)-DL-ornithine Hydrochloride Hydrate; 2- (Difluoromethyl) ornithine; DFMO; DL-2- (Difluoromethyl) ornithine; DL-α - (Difluoromethyl) ornithine; Elfornithine; MDL 71782; MDL 71782A; Ornidyl; RFI 71782; RMI 71782; α , δ -Diamino-α - (difluoromethyl) valeric Acid; α-(Difluoromethyl)-DL-ornithine; α - (Difluoromethyl) ornithine. Grades: Highly Purified. CAS No. 96020-91-6. Pack Sizes: 50mg, 100mg, 250mg, 500mg, 1g. Molecular Formula: C?H??ClF?N?O?, Molecular Weight: 236.64. US Biological Life Sciences.
Worldwide
Efloxate
Efloxate, a flavone derivative, could be effective in the treatment of chronic coronary insufficiency and angina pectoris for acting as a vasodilator. Uses: Efloxate could be effective in the treatment of chronic coronary insufficiency and angina pectoris for acting as a vasodilator. Synonyms: RE 1-0185; RE-1-0185; RE1-0185; efloxate; EFLOXATE/EFLOXATEM; Corosamin; Domucor; Eflocor; Oxyflavyl; Recordil; 2-(4-keto-2-phenyl-chromen-7-yl)oxyacetic acid ethyl ester. Grade: 98%. CAS No. 119-41-5. Molecular formula: C19H16O5. Mole weight: 324.33.
Efmarodocokin alfa
Efmarodocokin alfa is a fusion protein of human IL-22 and the IgG4 crystallizable fragment. Efmarodocokin alfa activates IL-22 signaling. Efmarodocokin alfa can be used for the research of severe COVID-19 pneumonia [1]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 2247840-74-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99919.
Efonidipine
Efonidipine(NZ-105) is a dual T-type and L-type calcium channel blocker (CCB). Uses: Scientific research. Group: Signaling pathways. Alternative Names: NZ-105; (±)-Efonidipine. CAS No. 111011-63-3. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-12502.
EFONIDIPINE
Efonidipine could be effective in the treatment of cardiovascular disease as a blocker of T-type and L-type calcium channels. It could also present as the hydrochloride salt form. Uses: Efonidipine could be effective in the treatment of cardiovascular disease as a blocker of t-type and l-type calcium channels. Synonyms: NZ-105; NZ 105; NZ105; Efonidipine; Efonidipine[INN]; 111011-63-3; C34H38N3O7P; Efonidipine(INN); Landel. Grade: 95%. CAS No. 111011-63-3. Molecular formula: C34H38N3O7P. Mole weight: 631.66.
EFONIDIPINE HCL
The hydrochloride salt form of Efonidipine which could be effective in the treatment of cardiovascular disease as a blocker of T-type and L-type calcium channels. Uses: The hydrochloride salt form of efonidipine which could be effective in the treatment of cardiovascular disease as a blocker of t-type and l-type calcium channels. Synonyms: EFONIDIPINE HCL; Efonidipine hydrochloride. Grade: 95%. CAS No. 111011-53-1. Molecular formula: C34H38N3O7P.HCl. Mole weight: 668.12.
Efonidipine hydrochloride monoethanolate
The hydrochloride monoethanolate salt form of Efonidipine which has been launched for hypertension and discontinued for cerebrovascular disorders. Uses: The hydrochloride monoethanolate salt form of efonidipine which has been launched for hypertension and discontinued for cerebrovascular disorders. Synonyms: Efonidipine hydrochloride ethanol; Efonidipine hydrochloride ethanolate; NZ 105 ethanolate; NZ105 ethanolate; NZ-105 ethanolate; EFONIDIPINE HYDROCHLORIDE MONOETHANOLATE; 111011-76-8; Efonidipine.HCl ethanolate. Grade: >98%. CAS No. 111011-76-8. Molecular formula: C36H45ClN3O8P. Mole weight: 631.66.
Efonidipine hydrochloride monoethanolate (NZ-105 hydrochloride monoethanolate) is a dual T-type and L-type calcium channel blocker (CCB). Uses: Scientific research. Group: Signaling pathways. Alternative Names: NZ-105 hydrochloride monoethanolate. CAS No. 111011-76-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg. Product ID: HY-12502A.
Efonidipine hydrochloride monoethanolate
Efonidipine hydrochloride monoethanolate. Group: Biochemicals. Grades: Purified. CAS No. 111011-76-8. Pack Sizes: 10mg, 50mg. US Biological Life Sciences.
Worldwide
Efpeglenatide
Efpeglenatide is a long-acting glucagon-like peptide-1 receptor agonist (GLP-1RA). Efpeglenatide has been developed as an injection for type 2 diabetes mellitus (T2DM). Synonyms: efpeg. CAS No. 1296200-77-5.
Efrotomycin
It is produced by the strain of Streptomyces lavendulae. The combination of Efrotomycin with the prolonging factor Tu inhibits protein biosynthesis. It has anti-gram-positive bacteria and negative bacteria activity, and it can inhibit coccidiosis in mice and chickens and promote the growth of pigs. Synonyms: Producil; Antibiotic FR 02A; Efrotomicina; Efrotomycine; Mocimycin, 31-O-(6-deoxy-4-O-(6-deoxy-2,4-di-O-methyl-alpha-L-mannopyranosyl)-3-O-methyl-beta-D-allopyranosyl)-1-methyl-. CAS No. 56592-32-6. Molecular formula: C59H88N2O20. Mole weight: 1145.33.
Efruxifermin
Efruxifermin is an Fc-FGF21 fusion protein (human IgG1 Fc domain linked to a modified human FGF21). Efruxifermin has prolonged half-life and enhanced receptor affinity compared with native human FGF21. Efruxifermin can be used for the research of non-alcoholic steatohepatitis [1]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 2375240-92-7. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99930.
eFT-508 is a selective inhibitor of MNK1/2 (IC50s = 2.4 nM and 1 nM respectively) inhibiting MNK1/2-mediated signaling and the phosphorylation of certain regulatory proteins. It acts against tumor. Synonyms: SCHEMBL17362622; AKOS030627405; ZINC575623807; CS-5841; CS 5841; CS5841; 6-[(6-aminopyrimidin-4-yl)amino]-8-methylspiro[2H-imidazo[1,5-a]pyridine-3,1'-cyclohexane]-1,5-dione; eFT508. Grade: 98%. CAS No. 1849590-01-7. Molecular formula: C17H20N6O2. Mole weight: 340.38.
Eftilagimod alfa (IMP321) is a recombinant LAG-3Ig fusion protein that binds to MHC class II. Eftilagimod alfa mediates antigen-presenting cell (APC) activation followed by CD8 T-cell activation. Eftilagimod alfa can be used for metastatic melanoma and metastatic breast carcinoma research [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: IMP321; LAG-3Ig. CAS No. 1800476-36-1. Pack Sizes: 1 mg. Product ID: HY-P99933.
Eftozanermin alfa
Eftozanermin alfa (ABBV-621) is a second-generation tumor necrosis factor-related apoptosis-inducing ligand receptor ( TRAIL-R ) agonist. Eftozanermin alfa induces apoptosis in tumor cells by activation of death receptors 4/5. Eftozanermin alfa can be used for the research of multiple solid and heme malignancies [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: ABBV-621. CAS No. 1820660-69-2. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99934.
EFTUD2 (668-677)
EFTUD2 is required for pre-mRNA splicing as component of the spliceosome, including pre-catalytic, catalytic and post-catalytic spliceosomal complexes. Synonyms: Elongation Factor Tu GTP Binding Domain Containing 2 (668-677); 116 KDa U5 Small Nuclear Ribonucleoprotein Component (668-677); Elongation Factor Tu GTP-Binding Domain-Containing Protein 2 (668-677).
Efungumab
Efungumab is a human recombinant monoclonal antibody with antifungal activity. Efungumab binds to HSP 90, preventing a conformational change needed for fungal viability. Efungumab has the potential for the treatment of invasive candidiasis. Grade: 95%. CAS No. 762260-74-2.